Figure 2
![Figure 2. Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/119/21/10.1182_blood-2012-01-404194/4/zh89991289910002.jpeg?Expires=1735827309&Signature=kOGwGUAqTssqLOcICIOfAuk5OzIm~FhOXVPuS1d50~R~pGW937rqN-P-y0PIaq8UMNOzRUu19XB3WyVike3nCQO19XV6gcS2eCSXCDPBd5zc1UJ45VddqTNrdOHBabvmIUXgq1s40W5xC6UKKalXwr2Z~ia1Tk4a-hnX5pzxPW1IfX1E7LOIeJFQADeSnoFSb7myXtTXcFQAtQyH6jOtubITb~xMwjmXRjae9-eL2w4TN-awAdbhMffhIUQU39-JVIjJwzhRFDsQpQGtCQRjXw4mSX4tb62ferH1TekNXlG~q0YapE-4yNEtapkRjUu3vlkhp-u6ZH4nImMnA-0oyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).
Time to pCR of HP-eradicated patients. Time was calculated from the completion of antibiotic treatment to first evidence of pCR by Kaplan-Meier analysis (pure [de novo] DLBCL vs DLBCL[MALT]; P = .024, 2-sided, log-rank test).
